Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Search Inside the pdf :

Gennex Laboratories Ltd.

08 Sep 2025

12.61

-2.47%

Company Update

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find herewith Newspaper publication of AGM Notice and e-Voting related instructions advertisement published in Business Standard and Saksham (Local) on September 06, 2025 for the 40th Annual General Meeting of the Company to be held on September 30, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

08 Sep 2025

12.61

-2.47%

Corp. Note

Gennex Laboratories Ltd - 531739 - Reg. 34 (1) Annual Report.

BSE India

With reference to the subject matter, As per the Regulation 34 of SEBI (LODR) Regulations, 2015, we hereby submits 40th Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31, 2025, inter alia, Notice of the Annual General Meeting to be held on Tuesday, September 30, 2025, Director''s Report, Independent Audit Report of. Statutory Auditor, Financial Statements (Standalone and Consolidated), being Balance Sheet, Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31, 2025 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours. This intimation is also being uploaded on the Company website: www.gennexlab.com.

pdf

Gennex Laboratories Ltd.

04 Sep 2025

12.61

-2.47%

Corp. Action

Gennex Laboratories Ltd - 531739 - Intimation Of Book Closure For AGM

BSE India

Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Register of members and Share Transfer Books of the Company will remain closed from September 23, 2025 to September 30, 2025 (both days inclusive) for the purpose of 40th Annual General Meeting to be held on September 30, 2025 for the Financial year 2024-25. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

04 Sep 2025

12.61

-2.47%

Board Meeting

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for For Meeting Held On 04Th September …

BSE India

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors''/ Board Report for the Financial Year March 31, 2025; 2. The 40th Annual General Meeting of the Company to be held on Tuesday, September 30, 2025 at 12:30 P.M.; 3. Appointment of Ms. Priyanka Rajora, Practicing Company Secretary, Hyderabad as Scrutinizer for the AGM; 4. Book Closure Date in connection with 40th AGM between September 23, 2025 to September 30, 2025; 5. E-voting period from September 27, 2025 at 9.00 AM to September 29, 2025 at 5.00 PM with cut-off date September 23, 2025; 6. Appointment of Mr. Md. Tausif Shamim, Practicing Company Secretary, Kolkata as a Secretarial Auditor for five consecutive financial years from 2025-26 to 2029-30. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM. This intimation is also being uploaded on the Company website: www.gennexlab.com.

pdf

Gennex Laboratories Ltd.

26 Aug 2025

12.61

-2.47%

Board Meeting

Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Fixing Date, Time And Venue Of …

BSE India

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2025 ,inter alia, to consider and approve With reference to the above captioned subject matter, pursuant to the referred regulations of SEBI (LODR) Regulations, 2015 mentioned above, we hereby inform you that the Meeting of Board of Directors of the Company will be held on Thursday, September 04, 2025 at 04.00 P.M. at its Corporate Office at Akash Ganga, Plot 144, Srinagar Colony, Hyderabad, Telangana, 500073, inter alia, to consider the following matters, among other items of agenda: 1. To decide regarding the conduct of 40th AGM for the year ended March 31, 2025; 2. To Consider and Appoint Scrutinizer of the 40th Annual General Meeting in case of Finalisation of the Date of AGM; 3. Any other business with permission of the Chairperson. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

18 Aug 2025

12.61

-2.47%

Company Update

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30, 2025 announced by the Board of Directors in its meeting held on August 14, 2025. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on August 15, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

14 Aug 2025

12.61

-2.47%

Result

Gennex Laboratories Ltd - 531739 - Unaudited Financial Results For The Quarter Ended June 30, 2025

BSE India

In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2025 (annexed herewith); 2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the quarter ended June 30, 2025 (annexed herewith); 3. Other Business items. We hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 4.40 PM. This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	36.45	44.16	30.79	-17.5%	18.4%
Operating Profit Qtr	5.07	1.86	4.23	172.6%	19.9%
Net Profit Qtr	5.02	3.07	4.66	63.5%	7.7%
Earning Per Share Adjusted latest Qtr	0.21	0.13	0.19	61.5%	10.5%

* Consolidated data

Detailed Results

Gennex Laboratories Ltd.

14 Aug 2025

12.61

-2.47%

Board Meeting

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2025 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30, 2025 (annexed here with); 3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM. This intimation is also uploaded on the Company website: www.gennexlab.com We request you to take the above information on record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

07 Aug 2025

12.61

-2.47%

Company Update

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper publication regarding Meeting of Board of Directors of the Company scheduled to be held on Thursday, August 14, 2025 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30, 2025 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published both in Business Standard and Saksham (Local-Telugu) on August 05, 2025. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

28 Jul 2025

12.61

-2.47%

Company Update

Gennex Laboratories Ltd - 531739 - Approval Of Products From Drugs Control Administration, Government Of Andhra …

BSE India

We are pleased to inform that our subsidiary Company, M/s Deccan Remedies Limited, has received approval from Drug Control Administration, Government of Andhra Pradesh granting License for manufacture of Products under Form 25, Drug License No. 31/VP/AP/2014/B/R/CC, valid upto 28.05.2028. List of Products approved for manufacture and sale (Domestic and Export purpose) details as per letter attached. Drug License Approval received from the DCA, Government of Andhra Pradesh for the above mentioned products is enclosed with this letter for your information and for taking the same on record.

pdf

Is Gennex Laboratories Ltd. worth buying?

129 Votes:

Buy 83.72%

Sell 6.2%

Hold 10.08%